MICHELLE HUNT: Open Payments
NPI 1467702167 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 31 payments from 20 companies in 2025. Trend: 2023 $2,220 · 2024 $218 · 2025 $833
Food & beverage: $833
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $119 |
| Daiichi Sankyo Inc. | 4 | $99 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Geron Corporation | 2 | $58 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| TerSera Therapeutics LLC | 2 | $40 |
| Celgene Corporation | 2 | $35 |
| BeiGene USA, Inc. | 1 | $33 |
| Gilead Sciences, Inc. | 2 | $32 |
Products named: IMDELLTRA (AMG757), DATROWAY, RYTELO, BRUKINSA, KEYTRUDA, Trodelvy, OPDIVO, LONSURF.
Industry payments across NC — which companies pay providers there.
